Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endors (Q50672734)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 2016

Language	Label	Description	Also known as
English	Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endors	scientific article published in May 2016

Statements

scholarly article

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endors (English)

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

arterial hypertension

0 references

pulmonary vascular disease

1 reference

based on heuristic

inferred from title

congenital heart disease

1 reference

based on heuristic

inferred from title

pulmonary hypertension

1 reference

based on heuristic

inferred from title

author name string

Rainer Kozlik-Feldmann

1

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

Georg Hansmann

2

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

Damien Bonnet

3

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

Dietmar Schranz

4

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

Christian Apitz

5

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

Ina Michel-Behnke

6

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

language of work or name

0 references

publication date

1 May 2016

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

102 Suppl 2

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

ii42-8

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Updated Clinical Classification of Pulmonary Hypertension

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Diagnostics, monitoring and outpatient care in children with suspected pulmonary hypertension/paediatric pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The Eur

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Pulmonary arterial hypertension in congenital cardiac disease--the need for refinement of the Evian-Venice classification

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Classifying pulmonary hypertension in the setting of the congenitally malformed heart--cleaning up a dog's dinner

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Pediatric pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research [...]

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Congenital heart disease and pulmonary hypertension: pharmacology and feasibility of late surgery

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Effect of long term oxygen treatment at home in children with pulmonary vascular disease

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Nocturnal oxygen therapy in patients with the Eisenmenger syndrome

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Does anticoagulation in Eisenmenger syndrome impact long-term survival?

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Pharmacokinetic and hemodynamic responses to oral sildenafil during invasive testing in children with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Assessment of pulmonary endothelial function during invasive testing in children and adolescents with idiopathic pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Preoperative pulmonary hemodynamics and assessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation?

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Cardiac MR and CT imaging in children with suspected or confirmed pulmonary hypertension/pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Riociguat for pulmonary arterial hypertension associated with congenital heart disease.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Measurement, interpretation and use of haemodynamic parameters in pulmonary hypertension associated with congenital cardiac disease.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Pulmonary arterial hypertension: a comparison between children and adults

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Diagnosis and differential assessment of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Atrial septostomy in patients with pulmonary hypertension: should it be recommended?

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Potts shunt and atrial septostomy in pulmonary hypertension caused by left ventricular disease

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Perioperative care in patients with pulmonary hypertension after cardiac surgery: clinical management, outcome and future clinical research. Results from an expert meeting.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Flap valve double patch closure of ventricular septal defects in children with increased pulmonary vascular resistance.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

The effect of bosentan in patients with a failing Fontan circulation.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

The effect of bosentan on exercise capacity in Fontan patients; rationale and design for the TEMPO study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Iron deficiency is associated with adverse outcome in Eisenmenger patients

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-308378

21 January 2018

Identifiers

10.1136/HEARTJNL-2015-308378

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/27053697

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50672734&oldid=2094520310"